INTECH Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
INTECH Investment Management's JAZZ Position: Q2 2026 in Review
INTECH Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 8.7% in Q2 2026, buying an estimated $658K and bringing the position to 37,384 shares worth $9.01M. The position accounts for 0.08% of the portfolio, ranked #212.
INTECH Investment Management first reported a position in JAZZ in Q2 2022 and has held it in 16 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- INTECH Investment Management held 37,384 shares of Jazz Pharmaceuticals worth $9.01M as of Q2 2026.
- INTECH Investment Management bought 3,005 Jazz Pharmaceuticals shares in Q2 2026, an estimated $658K.
- Jazz Pharmaceuticals made up 0.08% of INTECH Investment Management's portfolio in Q2 2026, its #212 holding.
- INTECH Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.